Retinol Binding in Prostate Cancer
Author Information
Author(s): D. Boyd, P. Copestake, G.D. Chisholm, F.K. Habib
Primary Institution: University Medical School
Hypothesis
The study aims to compare retinol binding levels in human hyperplastic and malignant prostate tissues.
Conclusion
Malignant prostate tissue has a decreased ability to bind retinol compared to benign hyperplastic tissue.
Supporting Evidence
- Hyperplastic prostate cytosol bound an average of 4.0 pmol of retinol per mg of protein.
- Malignant prostate bound less retinol, averaging 1.7 pmol per mg of protein.
- All benign prostates tested were positive for cRBP, while some malignant glands were not.
Takeaway
This study found that cancerous prostate tissue doesn't hold onto vitamin A as well as non-cancerous tissue, which might be important for understanding prostate cancer.
Methodology
The study compared retinol binding in cytosol from hyperplastic and malignant prostate tissues using a retinol binding assay.
Limitations
The study did not find a correlation between cRBP levels and histological differentiation of the tumors.
Participant Demographics
Patients aged 50-70 years, with no prior therapy for cancer.
Statistical Information
P-Value
<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website